94 related articles for article (PubMed ID: 10404470)
1. Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients.
Zhu H; Halaris A; Madakasira S; Pazzaglia P; Goldman N; DeVane CL; Andrew M; Reis D; Piletz JE
J Psychiatr Res; 1999; 33(4):323-33. PubMed ID: 10404470
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment.
Halaris A; Zhu H; Ali J; Nasrallah A; Lindsay De Vane C; Piletz JE
Int J Neuropsychopharmacol; 2002 Mar; 5(1):37-46. PubMed ID: 12057030
[TBL] [Abstract][Full Text] [Related]
3. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists.
Ivanov TR; Feng Y; Wang H; Regunathan S; Reis DJ; Chikkala DN; Gupta P; Jones JC; Piletz JE
J Psychiatr Res; 1998; 32(2):65-79. PubMed ID: 9694002
[TBL] [Abstract][Full Text] [Related]
4. Plasma agmatine and platelet imidazoline receptors in depression.
Halaris A; Zhu H; Feng Y; Piletz JE
Ann N Y Acad Sci; 1999 Jun; 881():445-51. PubMed ID: 10415948
[TBL] [Abstract][Full Text] [Related]
5. Elevated P-selectin on platelets in depression: response to bupropion.
Piletz JE; Zhu H; Madakasira S; Pazzaglia P; Lindsay DeVane C; Goldman N; Halaris A
J Psychiatr Res; 2000; 34(6):397-404. PubMed ID: 11165307
[TBL] [Abstract][Full Text] [Related]
6. Platelet imidazoline receptors and regulatory G proteins in patients with major depression.
García-Sevilla JA; Escribá PV; Busquets X; Walzer C; Guimón J
Neuroreport; 1996 Dec; 8(1):169-72. PubMed ID: 9051774
[TBL] [Abstract][Full Text] [Related]
7. Imidazoline receptor proteins are decreased in the hippocampus of individuals with major depression.
Piletz JE; Zhu H; Ordway G; Stockmeier C; Dilly G; Reis D; Halaris A
Biol Psychiatry; 2000 Nov; 48(9):910-9. PubMed ID: 11074229
[TBL] [Abstract][Full Text] [Related]
8. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims.
García-Sevilla JA; Escribá PV; Sastre M; Walzer C; Busquets X; Jaquet G; Reis DJ; Guimón J
Arch Gen Psychiatry; 1996 Sep; 53(9):803-10. PubMed ID: 8792757
[TBL] [Abstract][Full Text] [Related]
9. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder.
Piletz JE; Halaris A; Nelson J; Qu Y; Bari M
J Psychiatr Res; 1996; 30(3):147-68. PubMed ID: 8884655
[TBL] [Abstract][Full Text] [Related]
10. Platelet imidazoline receptors as state marker of depressive symptomatology.
Piletz J; Baker R; Halaris A
J Psychiatr Res; 2008 Jan; 42(1):41-9. PubMed ID: 17166518
[TBL] [Abstract][Full Text] [Related]
11. Platelet I1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients.
Piletz JE; Halaris AE; Chikkala D; Qu Y
J Psychiatr Res; 1996; 30(3):169-84. PubMed ID: 8884656
[TBL] [Abstract][Full Text] [Related]
12. [Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)].
Szabó Z; Argyelán M; Kanyó B; Pávics L; Janka Z
Neuropsychopharmacol Hung; 2004 Jun; 6(2):79-81. PubMed ID: 15787205
[TBL] [Abstract][Full Text] [Related]
13. Bupropion in the management of apathy.
Corcoran C; Wong ML; O'Keane V
J Psychopharmacol; 2004 Mar; 18(1):133-5. PubMed ID: 15107198
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder.
Hewett K; Chrzanowski W; Jokinen R; Felgentreff R; Shrivastava RK; Gee MD; Wightman DS; O'Leary MC; Millen LS; Leon MC; Briggs MA; Krishen A; Modell JG
J Psychopharmacol; 2010 Apr; 24(4):521-9. PubMed ID: 19164492
[TBL] [Abstract][Full Text] [Related]
15. Nortriptyline toxicity secondary to interaction with bupropion sustained-release.
Weintraub D
Depress Anxiety; 2001; 13(1):50-2. PubMed ID: 11233461
[No Abstract] [Full Text] [Related]
16. Dysregulation of IRAS/nischarin and other potential I
Keller B; García-Sevilla JA
J Affect Disord; 2017 Jan; 208():646-652. PubMed ID: 27836117
[TBL] [Abstract][Full Text] [Related]
17. Density of imidazoline receptors in platelets of euthymic patients with bipolar affective disorder and in brains of lithium-treated rats.
García-Sevilla JA; Escribá PV; Ozaita A; Walzer C; Guimón J
Biol Psychiatry; 1998 Apr; 43(8):616-8. PubMed ID: 9564448
[TBL] [Abstract][Full Text] [Related]
18. Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study.
Modell JG; May RS; Katholi CR
J Sex Marital Ther; 2000; 26(3):231-40. PubMed ID: 10929571
[TBL] [Abstract][Full Text] [Related]
19. Co-detection by two imidazoline receptor protein antisera of a novel 85 kilodalton protein.
Ivanov TR; Zhu H; Regunathan S; Reis DJ; Dontenwill M; Vonthron C; Bousquet P; Piletz JE
Biochem Pharmacol; 1998 Mar; 55(5):649-55. PubMed ID: 9515575
[TBL] [Abstract][Full Text] [Related]
20. Bupropion normalizes cognitive performance in patients with depression.
Gualtieri CT; Johnson LG
MedGenMed; 2007 Jan; 9(1):22. PubMed ID: 17435629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
